arrow
H

Hans Raj Bhat

Dibrugarh University
H指数:27
被引数:2,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design and Discovery of Substituted 1,3,4-Thiadiazole-1,3,5-Triazine Hybrids as Human Immunodeficiency Virus-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Anti-SARS-CoV-2 and Antibacterial Activities

设计并发现取代的1,3,4-噻二唑-1,3,5-三嗪杂合物作为具有抗SARS-CoV-2和抗菌活性的人类免疫缺陷病毒-1非核苷类反转录酶抑制剂

2026-03-270
PRE
Microwave-Assisted Synthesis and In Vitro Anti-Alzheimer Evaluation of Novel 1,3,5-Triazine-Nicotinic Hydrazide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors

微波辅助合成及新型1,3,5-三嗪-烟酰肼衍生物在体外的抗阿尔茨海默病评价:作为乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂

2026-01-130
PRE
Design, discovery, molecular docking, dynamics and in-silico ADME-T evaluation of novel hybrids of 1,3,5-triazine-morpholi-no-thiazine as an anti-diabetic agent in Wistar rats via inhibition of DPP-4 (vol 1332, 141707, 2025)

设计、发现、分子对接、动力学及对新型1,3,5-三嗪-吗啉基-噻唑嗪杂交物的计算机辅助ADME-T评价,作为通过抑制DPP-4发挥作用的抗糖尿病药物(在Wistar大鼠中的研究)(卷1332,141707,2025)

2025-09-010
PRE
Design, discovery, molecular docking, dynamics and in-silico ADME-T evaluation of novel hybrids of 1,3,5-triazine-morpholino-thiazine as an anti-diabetic agent in Wistar rats via inhibition of DPP-4

1,3,5-三嗪-吗啉基噻嗪的新型杂合体的设计,发现,分子对接,动力学和硅adme-t评估通过抑制DPP-4在Wistar大鼠中作为抗糖尿病药

2025-06-010
PRE